Cited by 26Pharmacology and Obesity TreatmentPharmacovigilance and Adverse Drug ReactionsComplementary and Alternative Medicine Studies

Phenylpropanolamine and stroke: The study, the FDA ruling, the implications

VIDT, D. G., MERSFELDER, T. L.·2001·Cleveland Clinic Journal of Medicine

Abstract

Following a recent case-control study that linked the use of phenylpropanolamine (PPA) in diet aids to the risk of hemorrhagic stroke, the Food and Drug Administration requested that drug companies stop marketing products that contain PPA. Dozens of over-the-counter and prescription diet aids and cough and cold remedies will need to be reformulated or discontinued. This paper reviews the study and its implications for physicians.

Integrity signals

Registry

Crossref · 10.3949/ccjm.68.3.208

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cited by

Sorted by citations

Authors
VIDT, D. G., & MERSFELDER, T. L.
Affiliations
Ferris State University (US)
Venue
Cleveland Clinic Journal of Medicine
Published
2001-03-01
Volume
68
Issue
3
Pages
208-223
ISSN
  • 0891-1150 (ISSN-L)
  • 1939-2869
OpenAlex
W2090310866
Cited by
26
References
0
Citations by year
2025: 1 · 2018: 1 · 2017: 1 · 2016: 1
FWCI
1.99
Type
journal article
Language
en
Open access
closed
Locations
  • Cleveland Clinic Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology › Pharmacology and Obesity Treatment
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
  • Health Sciences › Medicine › Complementary and alternative medicine › Complementary and Alternative Medicine Studies
Keywords
phenylpropanolamine, hemorrhagic stroke, weight loss supplements, drug safety, over-the-counter drugs, cough and cold remedies, case-control study
MeSH terms
Adolescent, Adrenergic alpha-Agonists, Adult, Age Factors, Appetite Depressants, Child, Data Interpretation, Statistical, Nonprescription Drugs, Ephedrine, Female, Humans, Male, Middle Aged, Phenylpropanolamine, Drug Prescriptions, Risk Factors, Sex Factors, Sympathomimetics, Time Factors, United States, United States Food and Drug Administration, Nasal Decongestants, Odds Ratio, Case-Control Studies, Stroke

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review